Abbratech provides custom recombinant antibody discovery and development services using EPIVOLVE technology, which enables precise antibody engineering at nearly amino acid resolution. The company addresses the challenges of slow and inconsistent antibody development by producing high-affinity antibodies tailored to specific antigen sites, regardless of their immunogenicity or modification.

Aceiss integrates with existing application and security infrastructures to provide real-time visibility into user access and activity across technology stacks. This enables organizations to identify unauthorized access and anomalous behavior, thereby reducing their attack surface and improving compliance monitoring.

The startup provides psychiatric therapy through personalized treatment plans, utilizing live video consultations for psychiatric evaluations and medication management on a secure platform. This approach enables users to receive tailored medication solutions that meet their specific mental health needs.

Aeromics develops AER‑271, an intravenously administered small‑molecule inhibitor of aquaporin‑4 that blocks water influx at the blood‑brain barrier to prevent cerebral edema in acute ischemic stroke. The drug is formulated for rapid infusion in the hyper‑acute window and is currently in a biomarker‑driven Phase II trial targeting large hemispheric infarction, with potential expansion to other neuro‑edema conditions.

Allyx Therapeutics is a clinical-stage biotechnology company developing regenerative medicine therapies aimed at restoring neuronal function in patients with neurodegenerative diseases. Their approach focuses on enhancing cognitive health by targeting the underlying mechanisms of neurodegeneration.

AmpUp provides a software platform for managing electric vehicle (EV) charging stations, enabling seamless integration with various hardware options while offering features like access control and load management. The platform addresses the need for efficient and user-friendly charging solutions for drivers, hosts, and fleet operators in the expanding EV market.

Anonybit provides a privacy-preserving identity platform that secures the entire user journey from onboarding to passwordless login and account recovery. This platform utilizes patented, decentralized biometric storage to reduce fraud, enhance compliance, and improve user experience across digital, contact center, and physical channels. By offering a single, modular service layer, the company lowers the total cost of ownership associated with managing disparate identity point solutions.

Apriligen is developing APR-2020, an autologous gene therapy utilizing a lentiviral vector to correct the RPS19 gene in patients with Diamond Blackfan Anemia, a rare pediatric condition that causes severe red blood cell production failure. This therapy aims to eliminate the need for high-intensity chemotherapy and bone marrow transplants, offering a safer and potentially curative treatment option for affected children.

Arccos provides an IoT‑based golf performance platform that automatically records every shot using Bluetooth‑enabled club sensors and a phone‑free Link Pro tracker. The data are processed in the cloud to deliver real‑time Strokes Gained metrics, AI‑driven caddie recommendations, and post‑round analytics through a mobile app, with a subscription unlocking advanced insights and historical benchmarking.

Artizan Biosciences specializes in drug discovery and development targeting diseases linked to the human intestinal microbiota through advanced microbiome analysis and therapeutic interventions. The company aims to improve patient outcomes by developing precise treatments that restore microbial balance and enhance gut health.

Arvinas uses a proprietary PROTAC discovery engine to design bifunctional molecules that recruit E3 ubiquitin ligases and trigger proteasomal degradation of disease‑relevant proteins, expanding the druggable proteome for oncology and neurodegenerative indications. The company advances clinical‑stage degraders and offers partnership models for pharmaceutical and biotechnology companies to co‑develop or license these targeted protein‑degradation therapeutics.

Athletic Brewing Company produces a full line of award‑winning, craft‑style non‑alcoholic beers and sparkling hop waters with less than 0.5% ABV, delivering the aroma, body, and finish of traditional brews. The products are sold directly online across the U.S., with options for individual packs, curated variety packs, and a Subscribe & Save program, while the Athletic Club membership offers discounted pricing, free shipping, and exclusive releases.

AtlasXomics provides a spatial epigenome mapping solution at the single-cell level using the FlowGel220 kit, enabling precise analysis of gene regulation in oncology, neurology, and aging research. This technology addresses the need for high-resolution spatial context in epigenomic studies, facilitating a deeper understanding of cellular behavior and disease mechanisms.

Aware Recovery Care provides home‑based addiction treatment that combines in‑person nurse practitioner and counselor visits with telehealth and medication‑assisted therapy, organized into a four‑phase care pathway. The service uses a HIPAA‑compliant digital platform for real‑time dosing oversight, outcome tracking, and automated insurance billing, enabling flexible, reimbursable care for adults with substance use disorders.

Bags is a loan discovery platform that connects entrepreneurs with tailored funding solutions through personalized coaching and optimized accounting services. The platform addresses the challenge of accessing capital for growth by providing a curated network of lenders and financial planning support to help businesses scale effectively.

BEKhealth utilizes an AI-powered patient-matching platform that extracts structured and unstructured data from electronic medical records to identify clinically qualified participants for clinical trials. This technology enables organizations to enhance feasibility assessments and achieve up to 10 times more qualified patients and twice as fast enrollment compared to traditional methods.

This startup delivers a curated selection of alcohol-free wines, beers, and spirits directly to customers' doorsteps through a subscription model. By providing a diverse range of non-alcoholic beverages, it caters to individuals seeking healthier lifestyle choices without sacrificing the social experience of enjoying drinks.

Bexorg offers the BrainEx platform, a whole‑human brain perfusion system that keeps donated post‑mortem brains metabolically active for days, allowing precise delivery of drugs, biologics, or gene therapies across an intact blood‑brain barrier. Integrated AI analyzes longitudinal omics data to produce predictive models of disease and drug response, giving pharmaceutical and biotech companies translationally relevant preclinical data to de‑risk CNS programs and accelerate therapeutic discovery.

Biohaven Pharma is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for neuroscience, immunology, and oncology. Using proprietary modular drug development platforms and strategic collaborations, it accelerates the creation of treatments for high‑unmet‑need conditions such as epilepsy, spinal muscular atrophy, and rare neurogenetic disorders.

BiologicsMD provides a cloud‑based platform that centralizes experimental, manufacturing, and regulatory data for biologics development, creating a unified workspace for scientists, engineers, and compliance teams. The system offers automated workflows, predictive analytics, and role‑based security with audit trails, while integrating via APIs with existing LIMS, ERP, and ELN solutions to streamline collaboration and support FDA 21 CFR Part 11 compliance.

BioWave provides FDA‑cleared, high‑frequency neurostimulation devices that deliver non‑invasive electrical signals through the skin to block pain nerve transmission, offering drug‑free relief for acute and chronic pain. Its product line includes a portable home unit, a clinician‑supervised in‑office system, and a quick‑treatment pen, each capable of delivering up to 72 hours of analgesia from a single 30‑minute session and reducing reliance on medication.

Bloom Credit provides a RESTful API that enables companies to launch and manage lending products while accessing credit reports and reporting consumer payment behavior. This solution simplifies the integration process and ensures compliance with regulatory mandates, allowing businesses to focus on growth without the complexities of credit data management.

Bright Feeds utilizes artificial intelligence and drying technology to convert food waste into high-quality animal feed, providing a sustainable alternative to landfill disposal. This process not only reduces greenhouse gas emissions but also helps businesses lower waste management costs while meeting their sustainability goals.

Budderfly offers Energy-as-a-Service that handles audit, financing, installation, and continuous optimization of energy‑saving equipment for commercial and industrial facilities. Leveraging IoT sensors and cloud‑based analytics, it provides real‑time monitoring, AI‑driven demand‑side management, and predictive maintenance, with a zero‑upfront‑CAPEX model where fees are tied to verified utility savings.